These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 17507420

  • 1. Clinical implications of multiple drug resistance efflux pumps of pathogenic bacteria.
    Rouveix B.
    J Antimicrob Chemother; 2007 Jun; 59(6):1208-9. PubMed ID: 17507420
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria.
    Lomovskaya O, Watkins W.
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):225-36. PubMed ID: 11321578
    [Abstract] [Full Text] [Related]

  • 3. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U.
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [Abstract] [Full Text] [Related]

  • 4. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view.
    Lynch AS.
    Biochem Pharmacol; 2006 Mar 30; 71(7):949-56. PubMed ID: 16290174
    [Abstract] [Full Text] [Related]

  • 5. Bacterial efflux pump inhibitors from natural sources.
    Stavri M, Piddock LJ, Gibbons S.
    J Antimicrob Chemother; 2007 Jun 30; 59(6):1247-60. PubMed ID: 17145734
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of bacterial biocide and antibiotic resistance.
    Poole K.
    Symp Ser Soc Appl Microbiol; 2002 Jun 30; (31):55S-64S. PubMed ID: 12481829
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of bacterial biocide and antibiotic resistance.
    Poole K.
    J Appl Microbiol; 2002 Jun 30; 92 Suppl():55S-64S. PubMed ID: 12000613
    [Abstract] [Full Text] [Related]

  • 8. [MDR efflux pumps and antimicrobial resistance].
    Sánchez Díaz P.
    Rev Esp Quimioter; 2003 Jun 30; 16(2):172-87. PubMed ID: 12973455
    [Abstract] [Full Text] [Related]

  • 9. Role of efflux mechanisms on fluoroquinolone resistance in Streptococcus pneumoniae and Pseudomonas aeruginosa.
    Zhanel GG, Hoban DJ, Schurek K, Karlowsky JA.
    Int J Antimicrob Agents; 2004 Dec 30; 24(6):529-35. PubMed ID: 15555873
    [Abstract] [Full Text] [Related]

  • 10. Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.
    Lomovskaya O, Bostian KA.
    Biochem Pharmacol; 2006 Mar 30; 71(7):910-8. PubMed ID: 16427026
    [Abstract] [Full Text] [Related]

  • 11. Active efflux, a common mechanism for biocide and antibiotic resistance.
    Levy SB.
    J Appl Microbiol; 2002 Mar 30; 92 Suppl():65S-71S. PubMed ID: 12000614
    [Abstract] [Full Text] [Related]

  • 12. CRP regulator modulates multidrug resistance of Escherichia coli by repressing the mdtEF multidrug efflux genes.
    Nishino K, Senda Y, Yamaguchi A.
    J Antibiot (Tokyo); 2008 Mar 30; 61(3):120-7. PubMed ID: 18503189
    [Abstract] [Full Text] [Related]

  • 13. Non-antibiotics reverse resistance of bacteria to antibiotics.
    Kristiansen JE, Thomsen VF, Martins A, Viveiros M, Amaral L.
    In Vivo; 2010 Mar 30; 24(5):751-4. PubMed ID: 20952744
    [Abstract] [Full Text] [Related]

  • 14. Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy.
    Mahamoud A, Chevalier J, Alibert-Franco S, Kern WV, Pagès JM.
    J Antimicrob Chemother; 2007 Jun 30; 59(6):1223-9. PubMed ID: 17229832
    [Abstract] [Full Text] [Related]

  • 15. [Efflux-mediated antibiotics resistance in bacteria].
    Cattoir V.
    Pathol Biol (Paris); 2004 Dec 30; 52(10):607-16. PubMed ID: 15596311
    [Abstract] [Full Text] [Related]

  • 16. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance].
    Doléans-Jordheim A, Michalet S, Bergeron E, Boisset S, Souard F, Dumontet C, Dijoux-Franca MG, Freney J.
    Ann Biol Clin (Paris); 2008 Dec 30; 66(5):499-508. PubMed ID: 18957338
    [Abstract] [Full Text] [Related]

  • 17. Bacterial efflux pump inhibition.
    Kaatz GW.
    Curr Opin Investig Drugs; 2005 Feb 30; 6(2):191-8. PubMed ID: 15751743
    [Abstract] [Full Text] [Related]

  • 18. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
    Gad GF, El-Domany RA, Zaki S, Ashour HM.
    J Antimicrob Chemother; 2007 Nov 30; 60(5):1010-7. PubMed ID: 17906321
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of bacterial efflux pumps: a new strategy to combat increasing antimicrobial agent resistance.
    Kaatz GW.
    Expert Opin Emerg Drugs; 2002 Oct 30; 7(2):223-33. PubMed ID: 15989546
    [Abstract] [Full Text] [Related]

  • 20. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.
    Vila J, Martí S, Sánchez-Céspedes J.
    J Antimicrob Chemother; 2007 Jun 30; 59(6):1210-5. PubMed ID: 17324960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.